| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SMARCA5_0001400 | Exon-Exon | chr4:144445520-144447613 | chr4:143524367-143526460 | 382 nt | 0.3979 |
| hsa_SMARCA5_0001500 | Exon-Exon | chr4:144445520-144456117 | chr4:143524367-143534964 | 849 nt | 0.3852 |
| hsa_SMARCA5_0001600 | Exon-Exon | chr4:144445520-144457831 | chr4:143524367-143536678 | 1076 nt | 0.3838 |
| hsa_SMARCA5_0001700 | Exon-Exon | chr4:144445520-144466000 | chr4:143524367-143544847 | 1864 nt | 0.3922 |
| hsa_chr4_0157500 | Intergenic-Intergenic | chr4:144445530-144447574 | chr4:143524377-143526421 | 333 nt | 0.4054 |
| hsa_SMARCA5_0001800 | Exon-Exon | chr4:144445551-144457670 | chr4:143524398-143536517 | 884 nt | 0.3790 |
| hsa_SMARCA5_0002100 | Exon-Exon | chr4:144446604-144447613 | chr4:143525451-143526460 | 101 nt | 0.3861 |
| hsa_SMARCA5_0002200 | Exon-Exon | chr4:144446604-144449867 | chr4:143525451-143528714 | 107 nt | 0.3925 |
| hsa_SMARCA5_0002300 | Exon-Exon | chr4:144446604-144457831 | chr4:143525451-143536678 | 101 nt | 0.3861 |
| hsa_SMARCA5_0002400 | Exon-Exon | chr4:144446604-144465125 | chr4:143525451-143543972 | 126 nt | 0.3571 |
A study in mice demonstrated that the circSMARCA5 promotes angiogenesis by sponging SRSF1 mRNA to regulate VEGF-A [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. A study in human bloodstains demonstrated that the circSMARCA5 exhibited linear degradation over 120 days, with its relative expression negatively correlated with bloodstain age both indoors (r=0.81) and outdoors (r=0.91), and it was incorporated into a mathematical formula for estimating the time since deposition [Wei et al. DOI:10.1016/j.forsciint.2022.111408]. A separate review noted that in human plasma, the circSMARCA5 is lower in patients with more severe coronary atherosclerosis, with an AUC of 0.589, indicating its potential as a diagnostic biomarker for stable coronary artery disease [Tian et al. DOI:10.3390/molecules26041155].